Correlation Between Kalvista Pharmaceuticals and Inozyme Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kalvista Pharmaceuticals and Inozyme Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kalvista Pharmaceuticals and Inozyme Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kalvista Pharmaceuticals and Inozyme Pharma, you can compare the effects of market volatilities on Kalvista Pharmaceuticals and Inozyme Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kalvista Pharmaceuticals with a short position of Inozyme Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kalvista Pharmaceuticals and Inozyme Pharma.

Diversification Opportunities for Kalvista Pharmaceuticals and Inozyme Pharma

0.89
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Kalvista and Inozyme is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Kalvista Pharmaceuticals and Inozyme Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inozyme Pharma and Kalvista Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kalvista Pharmaceuticals are associated (or correlated) with Inozyme Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inozyme Pharma has no effect on the direction of Kalvista Pharmaceuticals i.e., Kalvista Pharmaceuticals and Inozyme Pharma go up and down completely randomly.

Pair Corralation between Kalvista Pharmaceuticals and Inozyme Pharma

Given the investment horizon of 90 days Kalvista Pharmaceuticals is expected to generate 0.45 times more return on investment than Inozyme Pharma. However, Kalvista Pharmaceuticals is 2.22 times less risky than Inozyme Pharma. It trades about 0.0 of its potential returns per unit of risk. Inozyme Pharma is currently generating about -0.47 per unit of risk. If you would invest  876.00  in Kalvista Pharmaceuticals on October 25, 2024 and sell it today you would lose (12.00) from holding Kalvista Pharmaceuticals or give up 1.37% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Kalvista Pharmaceuticals  vs.  Inozyme Pharma

 Performance 
       Timeline  
Kalvista Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Kalvista Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Inozyme Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Inozyme Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kalvista Pharmaceuticals and Inozyme Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kalvista Pharmaceuticals and Inozyme Pharma

The main advantage of trading using opposite Kalvista Pharmaceuticals and Inozyme Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kalvista Pharmaceuticals position performs unexpectedly, Inozyme Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inozyme Pharma will offset losses from the drop in Inozyme Pharma's long position.
The idea behind Kalvista Pharmaceuticals and Inozyme Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamental Analysis
View fundamental data based on most recent published financial statements
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios